Medtronic gains CE mark for Viva/Brava portfolio of CRT-D devices
06:58 EDT 21 Aug 2012 | Medical Business Review
Medtronic has gained CE mark for its Viva/Brava portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices.
Original Article: Medtronic gains CE mark for Viva/Brava portfolio of CRT-D devices
More From BioPortfolio on "Medtronic gains CE mark for Viva/Brava portfolio of CRT-D devices"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
